Strong company earnings boosted stocks on Wall Street Friday. Investors also saw a chance to add to their holdings after declines earlier in the week.
Nike reported a surge in quarterly profit, sending its stock price to a record. Tiffany topped earnings predictions, boosted by demand from customers in Asia.
Investors were also drawn by a pause in the market’s big run-up. The Standard & Poor’s 500 index logged its second weekly decline of the year, despite Friday’s gains.
The damper on U.S. stock markets was caused by another worrisome chapter in Europe’s debt crisis, and some disappointing corporate news.
The Mediterranean island nation of Cyprus, a banking haven, is struggling to devise a plan to avoid financial collapse. Stocks were also weighed down on Thursday by weak sales from Oracle. That news brought down technology stocks.
FedEx ended the week 10 percent lower after it reported a drop in quarterly profit and cut its annual earnings forecast on Wednesday. The company is a gauge of the economy because so many shoppers and businesses use its shipping services.
On Friday, investors took advantage of the market’s down week and ramped up their stock buying.
A resilient global economy has encouraged investors to pick up stocks on any dips, said Ron Florance, managing director of investment strategy at Wells Fargo Private Bank.
The Dow Jones industrial average rose 90.54 points, or 0.6 percent, to 14,512.03 Friday. The Standard & Poor’s 500 index rose 11.09 points, or 0.7 percent, to 1,556.89. The Nasdaq composite gained 22.40 points, or 0.7 percent, to 3,245.
Nike shares hit an all-time high, rising $5.93, or 11 percent, to $59.53 after the company reported a 55 percent spike in quarterly net income. Tiffany rose $1.32, or 1.9 percent, to $69.23 after its strong fourth-quarter earnings.
The yield on the 10-year Treasury note rose to 1.93 percent from 1.92 percent.
Among other stocks making big moves Friday;
c Micron Technology rose 97 cents, or 10.7 percent, to $10.05 despite reporting a loss in its fiscal second-quarter later Thursday. The chipmaker said that revenue grew 3 percent, to $2.08 billion, better than analysts had expected.
c Anacor Pharmaceuticals Inc. climbed $1.24, or 25.6 percent, to $6.08 Friday, after the drug developer reported strong data from a mid-stage study of a potential chronic rash treatment.